Efficacy and safety of open‐label caplacizumab in patients with exacerbations of acquired thrombotic thrombocytopenic purpura in the HERCULES study

201963 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: Journal of Thrombosis and Haemostasis

Volume 18, Issue 2, pp. 479-484

Field-Weighted Citation Impact: 3.24